Scarica l'app Stockscreener
325.58
0.58%
1.89
Dopo l'orario di chiusura:
325.58
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$323.69
Aprire:
$323.03
Volume 24 ore:
158.54K
Relative Volume:
0.60
Capitalizzazione di mercato:
$9.06B
Reddito:
$2.58B
Utile/perdita netta:
$-778.69M
Rapporto P/E:
-55.65
EPS:
-5.85
Flusso di cassa netto:
$223.75M
1 W Prestazione:
-7.04%
1M Prestazione:
-5.11%
6M Prestazione:
+12.48%
1 anno Prestazione:
+6.34%
Intervallo 1D:
$320.32
$326.45
Intervallo di 1 settimana:
$306.42
$349.07
Portata 52W:
$262.12
$387.99
Bio Rad Laboratories Inc Stock (BIO) Company Profile
Nome
Bio Rad Laboratories Inc
Settore
Industria
Telefono
949-409-7600
Indirizzo
15 CUSHING, IRVINE
Confronta BIO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
| BIO | 325.58 | 9.06B | 2.58B | -778.69M | 223.75M | -5.85 |
| ABT | 117.26 | 201.11B | 41.22B | 5.77B | 6.49B | 2.94 |
| SYK | 390.14 | 148.40B | 21.97B | 3.59B | 3.21B | 6.74 |
| BSX | 91.50 | 134.72B | 15.91B | 1.79B | 1.89B | 0.82 |
| MDT | 84.74 | 108.57B | 33.00B | 4.29B | 5.50B | 2.71 |
| EW | 70.38 | 41.51B | 6.60B | 4.16B | 490.10M | 2.34 |
Bio Rad Laboratories Inc Stock (BIO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-10-01 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-08-28 | Iniziato | Wells Fargo | Equal Weight |
| 2024-06-03 | Ripresa | Jefferies | Hold |
| 2024-04-03 | Downgrade | Citigroup | Buy → Neutral |
| 2023-12-07 | Iniziato | UBS | Buy |
| 2023-06-16 | Iniziato | Wells Fargo | Overweight |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-01-28 | Reiterato | Citigroup | Buy |
| 2020-01-08 | Iniziato | Wells Fargo | Overweight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2018-10-17 | Iniziato | Goldman | Buy |
| 2018-09-20 | Iniziato | Morgan Stanley | Equal-Weight |
| 2018-02-16 | Downgrade | CL King | Buy → Neutral |
| 2017-07-13 | Iniziato | Wells Fargo | Outperform |
| 2017-06-28 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2017-01-18 | Iniziato | Deutsche Bank | Hold |
| 2016-10-13 | Iniziato | CL King | Buy |
| 2015-05-06 | Reiterato | Jefferies | Buy |
| 2009-12-18 | Iniziato | Maxim Group | Buy |
| 2009-11-06 | Iniziato | Jefferies & Co | Buy |
| 2009-07-17 | Iniziato | Soleil | Buy |
| 2007-09-26 | Iniziato | Banc of America Sec | Buy |
| 2007-02-23 | Downgrade | Robert W. Baird | Outperform → Neutral |
Mostra tutto
Bio Rad Laboratories Inc Borsa (BIO) Ultime notizie
Thompson Siegel & Walmsley LLC Sells 83,227 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
Bio-Rad’s Management to Host Investor Meetings at Citi's 2024 Global Healthcare Conference - Business Wire
One Step RT-qPCR Kits Market Key Players AnalysisTakara Bio - openPR
Natixis Advisors LLC Increases Stock Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
Leukemia Screening Market Future Business Opportunities - openPR
Custom Antibody Services Market Report: Detailed Insights - openPR
Cell Signaling Market: Opportunities, Challenges, and Growth - openPR
Electrophoresis Reagents Market: Company Profiles, Segment - openPR
Hematology Testing Products Market Statistical Forecast - openPR
Biological Multiplex Assays Market to Witness Significant - openPR
IVD quality control Market Share, Trends, Top Players, Segments - openPR
Biochips Market Opportunities and Trends With Leading Key - openPR
DNA Extraction Kits Market Is Booming Worldwide 2024-2031 | - openPR
Cell Viability Assays Market Opportunities and Trends - openPR
Molecular Quality Controls Market Size Analysis and Regional - openPR
Protein Engineering Market Projected to Reach USD 7.39 Billion by 2032 with a CAGR of 14.72% - GlobeNewswire Inc.
Mawer Investment Management Ltd. Boosts Stock Position in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
Protein Chip Market Growth, Industry Development and Forecast - openPR
Genomic Biomarker Market 2024 Opportunity, Challenge, - openPR
Laboratory Mixer Market Strong Industry Growth, Business - openPR
Research Antibodies Market Report Outlines Revenue Share, SWOT - openPR
Genomic Biomarker Market Dynamics and Forecast Comprehensive - openPR
Bio-Rad Laboratories, Inc. (NYSE:BIO) Stake Lowered by Sumitomo Mitsui Trust Group Inc. - MarketBeat
Sumitomo Mitsui Trust Group Inc. Trims Stock Position in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
Clinical Diagnostics Market to Reach $ 110.0 Billion by 2031 | - openPR
Multiplexed Diagnostics Market Share, Trends, Top Players, - openPR
Apoptosis Assays Market Analysis By Top KeyplayersMerck, - openPR
High-throughput Screening Technology Market Size and Regional An - News Channel Nebraska
Bio-Rad Laboratories, Inc. (NYSE:BIO) Stock Holdings Boosted by Principal Financial Group Inc. - MarketBeat
Evaluation of a New Multimodal Anion Exchange Resin for Emerging Biotherapeutic Process Challenges - BioProcess Insider
Short Interest in Bio-Rad Laboratories, Inc. (NYSE:BIO) Declines By 20.8% - MarketBeat
Chromatography Systems Market Industry Detailed Exploration, - openPR
VAN ECK ASSOCIATES CORP's Strategic Acquisition in Bio-Rad Labor - GuruFocus.com
Chiral Chromatography Columns Market Overall Study Report - openPR
Dental Services Market Overall Study Report 2024-2032 | Agilent - openPR
Genomics Market Overall Study Report 2024-2032 | Agilent - openPR
SEC Form SC 13G filed by Bio-Rad Laboratories Inc. - Quantisnow
Entropy Technologies LP Acquires Shares of 4,200 Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
4,200 Shares in Bio-Rad Laboratories, Inc. (NYSE:BIO) Bought by Entropy Technologies LP - MarketBeat
Bio-Rad Demonstrates Leadership Position in the Oncology Market at Association for Molecular Pathology 2024 - Technology Networks
Protein A Resin Market Growth, Size, Trends, Shares, By Top - openPR
Brokerages Set Bio-Rad Laboratories, Inc. (NYSE:BIO) Target Price at $391.80 - MarketBeat
Lung Cancer Diagnostics Market Anticipated for Positive Growth - openPR
Biochips Market Is Booming Worldwide 2024-2031 | Illumina, - openPR
Bio-Rad Laboratories: This Undervalued Stock Offers Investors a Rare Combination - Morningstar
ICICI Prudential Asset Management Co Ltd Raises Position in Bio-Rad Laboratories, Inc. (NYSE:BIO) - MarketBeat
What Makes Bio-Rad Laboratories (BIO) an Attractive Opportunity? - Insider Monkey
PCR Systems Market Growth, Industry Development and Forecast - openPR
Thalassemia Testing Market Ready to Rise Sharply On Superior - openPR
Bio-Rad demonstrates leadership position in the oncology market at Association for Molecular Pathology 2024 - Cambridge Network
Biosensors Market Is Booming Worldwide 2024-2031 | Bio-Rad - openPR
Bio Rad Laboratories Inc Azioni (BIO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.66%
0.80%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):